Logo image of QTRX

QUANTERIX CORP (QTRX) Stock Fundamental Analysis

NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock

9.72  +0.85 (+9.58%)

Premarket: 9.98 +0.26 (+2.67%)

Fundamental Rating

4

QTRX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 56 industry peers in the Life Sciences Tools & Services industry. QTRX has a great financial health rating, but its profitability evaluates not so good. QTRX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year QTRX has reported negative net income.
QTRX had a negative operating cash flow in the past year.
QTRX had negative earnings in each of the past 5 years.
QTRX had a negative operating cash flow in each of the past 5 years.
QTRX Yearly Net Income VS EBIT VS OCF VS FCFQTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

QTRX has a Return On Assets (-12.28%) which is comparable to the rest of the industry.
QTRX has a Return On Equity of -14.89%. This is in the better half of the industry: QTRX outperforms 60.71% of its industry peers.
Industry RankSector Rank
ROA -12.28%
ROE -14.89%
ROIC N/A
ROA(3y)-13.48%
ROA(5y)-15.21%
ROE(3y)-16.07%
ROE(5y)-19.04%
ROIC(3y)N/A
ROIC(5y)N/A
QTRX Yearly ROA, ROE, ROICQTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K

1.3 Margins

QTRX's Gross Margin of 58.04% is fine compared to the rest of the industry. QTRX outperforms 76.79% of its industry peers.
QTRX's Gross Margin has improved in the last couple of years.
QTRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y4.96%
QTRX Yearly Profit, Operating, Gross MarginsQTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

QTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QTRX has been increased compared to 1 year ago.
QTRX has more shares outstanding than it did 5 years ago.
QTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QTRX Yearly Shares OutstandingQTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
QTRX Yearly Total Debt VS Total AssetsQTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

QTRX has an Altman-Z score of 2.37. This is not the best score and indicates that QTRX is in the grey zone with still only limited risk for bankruptcy at the moment.
QTRX has a Altman-Z score of 2.37. This is comparable to the rest of the industry: QTRX outperforms 51.79% of its industry peers.
QTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.37
ROIC/WACCN/A
WACC10.63%
QTRX Yearly LT Debt VS Equity VS FCFQTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 10.07 indicates that QTRX has no problem at all paying its short term obligations.
The Current ratio of QTRX (10.07) is better than 91.07% of its industry peers.
A Quick Ratio of 9.16 indicates that QTRX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 9.16, QTRX belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 9.16
QTRX Yearly Current Assets VS Current LiabilitesQTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.05% over the past year.
Looking at the last year, QTRX shows a very strong growth in Revenue. The Revenue has grown by 42.21%.
QTRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.62% yearly.
EPS 1Y (TTM)67.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.45%
Revenue 1Y (TTM)42.21%
Revenue growth 3Y12.3%
Revenue growth 5Y26.62%
Sales Q2Q%13.93%

3.2 Future

QTRX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.84% yearly.
Based on estimates for the next years, QTRX will show a quite strong growth in Revenue. The Revenue will grow by 15.76% on average per year.
EPS Next Y-12.87%
EPS Next 2Y-1.09%
EPS Next 3Y8.61%
EPS Next 5Y-2.84%
Revenue Next Year13.11%
Revenue Next 2Y14.22%
Revenue Next 3Y15.78%
Revenue Next 5Y15.76%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
QTRX Yearly Revenue VS EstimatesQTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
QTRX Yearly EPS VS EstimatesQTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QTRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTRX Price Earnings VS Forward Price EarningsQTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTRX Per share dataQTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.09%
EPS Next 3Y8.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QTRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTERIX CORP

NASDAQ:QTRX (1/21/2025, 8:22:58 PM)

Premarket: 9.98 +0.26 (+2.67%)

9.72

+0.85 (+9.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners86.37%
Inst Owner Change0.12%
Ins Owners6.53%
Ins Owner Change0.47%
Market Cap374.41M
Analysts81.67
Price Target20.11 (106.89%)
Short Float %5.8%
Short Ratio4.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.22%
Min Revenue beat(2)0.02%
Max Revenue beat(2)2.42%
Revenue beat(4)3
Avg Revenue beat(4)1.38%
Min Revenue beat(4)-0.58%
Max Revenue beat(4)3.65%
Revenue beat(8)6
Avg Revenue beat(8)5.29%
Revenue beat(12)9
Avg Revenue beat(12)2.72%
Revenue beat(16)13
Avg Revenue beat(16)5.27%
PT rev (1m)-2.82%
PT rev (3m)-3.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.68%
EPS NY rev (1m)0%
EPS NY rev (3m)1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.52%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.26
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS4.31
BVpS8.8
TBVpS8.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.28%
ROE -14.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.04%
FCFM N/A
ROA(3y)-13.48%
ROA(5y)-15.21%
ROE(3y)-16.07%
ROE(5y)-19.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y4.96%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.94%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.07
Quick Ratio 9.16
Altman-Z 2.37
F-Score4
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)187.1%
Cap/Depr(5y)202.59%
Cap/Sales(3y)8.86%
Cap/Sales(5y)10.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.45%
EPS Next Y-12.87%
EPS Next 2Y-1.09%
EPS Next 3Y8.61%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)42.21%
Revenue growth 3Y12.3%
Revenue growth 5Y26.62%
Sales Q2Q%13.93%
Revenue Next Year13.11%
Revenue Next 2Y14.22%
Revenue Next 3Y15.78%
Revenue Next 5Y15.76%
EBIT growth 1Y-49.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.57%
EBIT Next 3Y14.15%
EBIT Next 5Y18.35%
FCF growth 1Y37.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.36%
OCF growth 3YN/A
OCF growth 5YN/A